Swiss pharmaceutical giant Novartis has raised its full-year earnings forecast, citing robust revenue growth from key…
Speed bumps ahead? Goldman Sachs downgrades outlook on Indian stocks, lowers Nifty 12-month target to 27K
Goldman Sachs Group Inc. has downgraded its outlook on Indian equities from overweight to neutral, citing…